Skip to main content
. 2003 Jan;77(1):105–114. doi: 10.1128/JVI.77.1.105-114.2003

TABLE 2.

Expression of genes in the Ras and Notch pathways

Gene Fold changea
BM Spleen
Ras-associated genes
    Ki-Ras −1.5 ± 0.1 2.7 ± 0.2
    PAC-1 ERK/MAPK phosphataseb −2.3 ± 0.1 −2.2 ± 0.2
    Kinase suppressor of Ras (KSR1)b 2.5 ± 0.3 −2.5 ± 0.2
    Rho A GTPase −2.8 ± 0.3 −1.1 ± 0.2
    Rho B GTPase −2.4 ± 0.3 2.4 ± 0.2
    Raf −5.2 ± 0.5 −1.0 ± 0.3
    GBP-2 GTPase −3.3 ± 0.3 3.4 ± 0.2
    SOS-2 −2.7 ± 0.3 1.3 ± 0.2
    Vav −2.8 ± 0.3 1.7 ± 0.2
    DAB-2 −3.2 ± 0.3 1.0 ± 0.2
    ERK-1 −2.2 ± 0.2 −1.2 ± 0.2
    ERK-5 −5.6 ± 0.3 1.7 ± 0.5
    MEK-5 −3.3 ± 0.2 −1.3 ± 0.1
Notch-associated genes
    Delta (Dlk1-like) 2.7 ± 0.2 −2.3 ± 0.2
    Enhancer of Split (mESG) 2.2 ± 1.0 −1.2 ± 0.2
    Suppressor of Hairless (RBP-L) 1.4 ± 0.2 2.3 ± 0.3
    Sel 11 inhibitor of Notchb −3.0 ± 0.2 4.2 ± 0.1
a

Identical microarray experiments were performed in duplicate with CD19+ bone marrow (BM) and splenic B cells from wild-type and LMP2A transgenic mice. The average fold change in gene expression in cells from LMP2A transgenic mice versus wild-type mice from the two experiments is shown, along with the standard deviation. Negative values indicate decreased expression.

b

Shown to be a positive or negative regulator, depending on the model system.